Intelligent classification of platelet aggregates by agonist type.

Area of Science:

• Hematology
• Computational Biology
• Biomedical Engineering

Background:

• Platelets are crucial for hemostasis but also implicated in thrombosis, inflammation, atherosclerosis, and cancer metastasis.
• Platelet aggregates, vital in physiological and pathological processes, have been difficult to distinguish and classify by agonist.
• Understanding platelet aggregation mechanisms is essential for developing targeted therapies.

Purpose of the Study:

• To develop an intelligent method for classifying platelet aggregates based on the specific agonist that induced their formation.
• To differentiate subtle morphological features of platelet aggregates activated by various agonists.

Main Methods:

• Utilized a convolutional neural network (CNN) model.
• Trained the CNN using high-throughput imaging flow cytometry data of blood cells.
• The model identifies and differentiates morphological characteristics of activated platelet aggregates.

Main Results:

• Successfully developed a method to classify platelet aggregates by agonist type.
• The AI model can differentiate subtle morphological differences in platelet aggregates.
• Demonstrated the potential for high-throughput analysis and classification.

Conclusions:

• The developed AI method offers a powerful tool for studying platelet aggregation mechanisms.
• This classification approach is expected to advance clinical diagnostics, pharmacometrics, and therapeutics.
• Opens new avenues for understanding and targeting platelet-mediated diseases.